Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.29
Delayed Data
As of Apr 17
 -0.02 / -1.53%
Today’s Change
0.75
Today|||52-Week Range
1.66
+30.43%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close1.31
Today’s open1.37
Day’s range1.26 - 1.48
Volume6,285,213
Average volume (3 months)441,880
Market cap$57.0M
Dividend yield--
Data as of 4:00pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+82.79%
Earnings growth (this year)--
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-9.63%
P/E ratio2.0
Price/Sales1.54
Price/Book1.92

Competitors

 Today’s
change
Today’s
% change
APDNApplied DNA Sciences...-0.02-0.92%
PRANPrana Biotechnology ...+0.01+0.89%
ONTXOnconova Therapeutic...+0.11+4.87%
MTEXMannatech Inc-0.56-2.74%
Data as of 3:59pm ET, 04/17/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$31.2M
Annual profit (last year)$28.8M
Net profit margin92.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, COO &
Secretary
George W. Hebard
Chief Financial Officer &
Vice President-Finance
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers